PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Synergistic protection of matrine and lycopene against lipopolysaccharide-induced acute lung injury in mice

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31180535 ↗2019Reported benefit

Synergistic protection of matrine and lycopene against lipopolysaccharide-induced acute lung injury in mice

MouseEndotoxin/LPSBALB/cMalen = 36 male BALB/c mice randomised to 6 groups: control, 6 h li…Oral administration for matrine and lycopene; intraperitoneal injection for dexamethasone; intratracheal instillation for lipopolysaccharideMatrine 25 mg/kg and lycopene 100 mg/kg, given alone or in…Pretreatment given for 7 consecutive days before injury, with the final dose 30…

Model: Acute lung injury induced by intratracheal instillation of Escherichia coli 055:B5 lipopolysaccharide at 5 mg/kg, with tissue harvested 6 h later; control mice received intratracheal saline

Combined matrine and lycopene significantly reduced the lipopolysaccharide-induced rise in lung wet-to-dry weight ratio and attenuated haemorrhage, alveolar wall thickening, alveolar collapse and inflammatory infiltration, with a Q value of 1.27 for the lung injury score indicating synergy. The com…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.